Manasi Jaiman - Jun 11, 2025 Form 4 Insider Report for Aardvark Therapeutics, Inc. (AARD)

Role
Chief Medical Officer
Signature
/s/ Nelson Sun, as Attorney-in-Fact
Stock symbol
AARD
Transactions as of
Jun 11, 2025
Transactions value $
$0
Form type
4
Date filed
6/13/2025, 04:05 PM
Previous filing
Feb 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jaiman Manasi Chief Medical Officer C/O AARDVARK THERAPEUTICS, INC., 4370 LA JOLLA VILLAGE DRIVE, SUITE 1050, SAN DIEGO /s/ Nelson Sun, as Attorney-in-Fact 2025-06-13 0002045686

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AARD Stock Option (right to buy) Award $0 +127K $0.00 127K Jun 11, 2025 Common Stock 127K $11.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on June 11, 2026, and 1/48th of the shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive.